Press monitoring
The Federal Council brings new chemical legislation into force
1.12.2005 | Press monitoring
On 1st August 2005, the Federal Council will bring into force new legislation on chemical substances and the totally revised Ordinance concerning the placing of plant protection products on the market.
PhD scholarships in biomed
1.12.2005 | Press monitoring
Three times a year the Boehringer Ingelheim Fonds awards approximately 15 scholarships for two years for doctoral students in the field of biomedical basic research. An extension of the fellowship for another 12 months is possible. The next deadline for applications is February 1, 2006.
Genentech gives up Avastin development
1.12.2005 | Press monitoring
Genentech has announced that Avastin clinical trials in platinum-refractory ovarian cancer patients have been discontinued. The reason is that patients developed a serious bowel problem.
Gene therapy market suffers growth setbacks
1.12.2005 | Press monitoring
New analysis into the gene therapy market reveals that toxicological complications and poor therapy efficacy have hampered the growth of this sector in which new ways must be found to improve clinical efficiency and generate revenue.
Regenerating Worms Help Elucidate Stem Cell Biology
30.11.2005 | Press monitoring
Using a tiny flatworm best known for its extraordinary ability to regenerate lost tissue, researchers have identified a gene that controls the ability of stem cells to differentiate into specialized cells. The gene encodes a protein that is most similar to the protein PIWI, an important regulator of stem cells in organisms ranging from plants to...
The Earliest Animals Had Human-Like Genes
30.11.2005 | Press monitoring
Species evolve at very different rates, and the evolutionary line that produced humans seems to be among the slowest. The result, according to a new study by scientists at the European Molecular Biology Laboratory (EMBL), is that our species has retained characteristics of a very ancient ancestor that have been lost in more quickly-evolving...
Preclinical Studies Provide Additional Safety and Efficacy Evidence for VaxGen's Smallpox Vaccine Candidate
30.11.2005 | Press monitoring
Data from a series of preclinical studies presented by the Chemo-Sero Therapeutic Research Institute (KAKETSUKEN) at the 53rd Annual Conference of the Japanese Society of Virology provided additional evidence of the safety and efficacy of an attenuated smallpox vaccine being developed by VaxGen, Inc. (Pink Sheets: VXGN.PK). The attenuation refers...
Biotechnology and Genetic Diversity
25.11.2005 | Press monitoring
Experts say risks and benefits of biotechnology must be weighed on a case-by-case basis.
Insect-Resistant GM Rice in Farmers' Fields: Assessing Productivitz and Health Effects in China
25.11.2005 | Press monitoring
Although no country to date has released a major geneticallz modified [GM] food grain crop, China is on the threshold of commercializing GM rice. Farm surveys of randomly selected farm households that are cultivating the insect- resistand GM rice varieties, without the aid of experimental station technicians, demonstrate that when compared with...
Statins can help people with learning disabilities
24.11.2005 | Press monitoring
The latest study shows that statins, a class of cholesterol drugs, overcome the gene mutation which is cause of learning disabilities (such as neurofibromatosis 1-NF1).
